RRP ISA Survey Results
HOME
LEARN
Considerations for Newly Diagnosed Patients
FAQ
HPV Prevention and Treatment
Cervical Obsessions
Dropping the Ball
Educational Sweet Spot
Epidemiology
HPV and Oral Sex
HPV Disease
HPV Prevention
Kids and RRP (JOORP)
Kid-Specific Resources
Risk Factors for JOORP
Treatment-Related Issues
Managing HPV-16
by Bettie Steinberg, PhD
Novel Therapies (Artemisinin/Gardasil)
Artemisinin/Gardasil Ethical Issues
Artemisinin Patient Reports
Artemisinin Safety and Pharmacokinetics
Artemisinin Usage Guidelines (Part I)
Artemisinin Usage Guidelines (Part II)
Resistance to ART (cautionary note)
RRP ISA/RRPF Joint Letter on Artemisinin
Rumors of Toxicity, Ridicule and Racism
The Question of Medical Supervision
Wikipedia on Artemisinin
Pulmonary RRP
Resources
RRP Focus Sessions
2007 (Washington DC)
2005 (Los Angeles)
2005 (Vanvouver BC)
2004 (New York City)
2002 (San Diego)
Treatment Strategies
HOW YOU CAN HELP
Advocacy
Empowering Patients
Kathy Story (2005)
Kristina's Story (1999)
Sanford Foundation Initiative
Sherry's Story (2008)
Corporate Partners and Affiliates
Donate
Participate
Volunteer
Why Volunteer?
PROFESSIONALS & RESEARCHERS
Cidofovir (by RRP Taskforce, Cautionary)
Grant -Making
In the News
News About RRP
News About HPV
News About RRP ISA
Informed Consent on MMR, etc. (by Bettie Steinberg, PhD)
Library
A Bronchoscopic Picture Atlas
Data Trends Reports
HPV Vaccines
Popular Press
Rare Disease Illuminates Cancer's Early Stages
Research Articles (RRP)
RRP Taskforce
RRP ISA/RRPF Joint Letter on Artemisinin
RRP ISA's Resignation from the RRP Task Force
RRP Research & Treatment Protocols
Celebrex
Dr. Ian Frazer (RRP Therapeutic)
Pulsed-Dye Laser and DIM in Children
Pulsed-Dye Laser for Children
COMMUNICATE
RRP Forum
RRP ISA Newsletter
Newsletter 2/7/08
Newsletter 3/4/08
Newsletter 4/29/08
Newsletter 6/26/08
Newsletter: 9-27-08
Newsletter: 11-19-08
Newsletter: 4-22-09
RRP Shout Blog
ABOUT US
Accomplishments
Mission and Goals
Brochure
Contact Us
Organizational Structure
Board and Staff
Scientific Advisory Panel
Communicate
RRP Forum
RRP ISA Newsletter
RRP Shout Blog
(Important Disclaimer)
Order copies
Communicate
Home
»
Communicate
»
RRP ISA Newsletter
»
Newsletter 6/26/08
Newsletter 6/26/08
Cancellation of RRP Focus Session Originally Scheduled Sept. 20th:
http://rrpwebsite.org/forum/index.cfm?page=topic&topicID=96
In the News
News about RRP
Scientists develop new cancer-killing compound (ART at Univ. of WA.)
RRP ISA/RRPF Joint Letter on Artemisinin
FEMA trailers toxic, tests show
Pulmonary RRP (Tarceva and Celebrex)
Nventa completes evaluation of second cohort in HspE7 Phase 1 cervical dysplasia trial
Artemisinin & Gardasil Success Story + Updates
"Genetics of Papilloma-induced Voice Disturbance" Report
News about HPV
Sanford Foundation Initiative
Gardasil Considered No Longer "Worth It"
Avesthagen partners with ShigaMediX to develop vaccines for cervical cancer
Clueless on STDs, Throat Cancer, and Oral Sex
HPV Today (winter 2008 newsletter)
Tattooing improves response to DNA vaccine
HPV causing more oral cancer in men
Head and Neck Cancer HPV Involvement
HPV Today (fall 2007 newsletter)
Symposium on New HPV Prophylactic Vaccines
AAV2
Case report of a laryngeal squamous cell carcinoma treated with artesunate (artemisinin analogue)
News about RRP ISA
Cancellation of Sept. 20, 2008 RRP Focus Session
New RRP ISA Website
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
OpenCube - The Internets #1 CSS Menu, Drop Down Menu, Flyout Menu, and Pop Up menu Developer